TUESDAY, June 7, 2022 (HealthDay News) For individuals with obesity, tirzepatide is associated with lasting weight loss, according to a study published online June 4 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 3 to 7 in New Orleans. Ania M.
TUESDAY, June 7, 2022 (HealthDay News) For individuals with obesity, tirzepatide is associated with lasting weight loss, according to a study published online June 4 in the New England
A drug recently approved for type 2 diabetes in the United States is also very effective for treating obesity and has shown better weight loss than any previous medication, according to results from a new clinical trial.
American Diabetes Association Symposium to Highlight Once Weekly Drug as Potential Treatment for Obesity Today, findings from SURMOUNT-1, the first investigational phase 3 trial evaluating the safety and efficacy of tirzepatide for the treatment of obesity, were announced, representing a new class of medicines being studied for the treatment of obe